Global Medical REIT Inc. (NYSE:GMRE - Get Free Report) CEO Mark Okey Decker, Jr. acquired 57,332 shares of the business's stock in a transaction on Wednesday, June 25th. The shares were bought at an average price of $6.50 per share, for a total transaction of $372,658.00. Following the acquisition, the chief executive officer now owns 160,000 shares in the company, valued at approximately $1,040,000. This trade represents a 55.84% increase in their position. The transaction was disclosed in a legal filing with the SEC, which is available through this hyperlink.
Global Medical REIT Stock Up 0.1%
NYSE:GMRE traded up $0.01 during trading hours on Friday, hitting $6.75. 1,020,815 shares of the stock traded hands, compared to its average volume of 493,056. The firm has a 50 day moving average price of $6.78 and a 200 day moving average price of $7.64. The company has a current ratio of 0.26, a quick ratio of 0.26 and a debt-to-equity ratio of 1.44. Global Medical REIT Inc. has a fifty-two week low of $6.06 and a fifty-two week high of $10.46. The firm has a market cap of $451.04 million, a price-to-earnings ratio of 224.91, a PEG ratio of 1.15 and a beta of 1.14.
Global Medical REIT (NYSE:GMRE - Get Free Report) last posted its quarterly earnings results on Wednesday, May 7th. The company reported $0.22 EPS for the quarter, hitting the consensus estimate of $0.22. The business had revenue of $34.60 million during the quarter, compared to analysts' expectations of $35.49 million. Global Medical REIT had a net margin of 5.87% and a return on equity of 1.68%. Equities research analysts anticipate that Global Medical REIT Inc. will post 0.81 earnings per share for the current year.
Global Medical REIT Cuts Dividend
The business also recently declared a quarterly dividend, which will be paid on Wednesday, July 9th. Investors of record on Friday, June 20th will be issued a dividend of $0.15 per share. This represents a $0.60 annualized dividend and a dividend yield of 8.90%. Global Medical REIT's dividend payout ratio is currently 2,000.00%.
Wall Street Analysts Forecast Growth
GMRE has been the topic of several analyst reports. Robert W. Baird dropped their target price on shares of Global Medical REIT from $10.00 to $9.00 and set a "neutral" rating on the stock in a research report on Thursday, May 8th. B. Riley initiated coverage on shares of Global Medical REIT in a research report on Thursday, April 3rd. They set a "neutral" rating and a $9.00 price objective on the stock. Finally, Wall Street Zen downgraded shares of Global Medical REIT from a "hold" rating to a "sell" rating in a research note on Thursday, May 22nd. One investment analyst has rated the stock with a sell rating, two have assigned a hold rating and two have issued a buy rating to the stock. Based on data from MarketBeat.com, Global Medical REIT currently has a consensus rating of "Hold" and an average price target of $10.44.
Read Our Latest Analysis on Global Medical REIT
Institutional Trading of Global Medical REIT
Several institutional investors have recently made changes to their positions in GMRE. Rhumbline Advisers boosted its holdings in shares of Global Medical REIT by 2.6% during the fourth quarter. Rhumbline Advisers now owns 108,862 shares of the company's stock worth $840,000 after purchasing an additional 2,731 shares during the period. New York State Common Retirement Fund boosted its holdings in shares of Global Medical REIT by 3.2% during the fourth quarter. New York State Common Retirement Fund now owns 94,158 shares of the company's stock worth $727,000 after purchasing an additional 2,900 shares during the period. Proficio Capital Partners LLC acquired a new stake in shares of Global Medical REIT during the fourth quarter worth approximately $178,000. Aew Capital Management L P acquired a new stake in shares of Global Medical REIT during the fourth quarter worth approximately $230,000. Finally, Charles Schwab Investment Management Inc. boosted its holdings in shares of Global Medical REIT by 2.8% during the fourth quarter. Charles Schwab Investment Management Inc. now owns 877,096 shares of the company's stock worth $6,771,000 after purchasing an additional 23,993 shares during the period. 57.52% of the stock is currently owned by institutional investors and hedge funds.
Global Medical REIT Company Profile
(
Get Free Report)
Global Medical REIT Inc (GMRE) is a net-lease medical office real estate investment trust (REIT) that owns and acquires healthcare facilities and leases those facilities to physician groups and regional and national healthcare systems.
Recommended Stories
Before you consider Global Medical REIT, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Global Medical REIT wasn't on the list.
While Global Medical REIT currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Enter your email address and we'll send you MarketBeat's list of seven best retirement stocks and why they should be in your portfolio.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.